Mease, Philip <br/><br/>
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.  [electronic resource] 

 -  Arthritis research & therapy  03 2020 
 - 43 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-020-2126-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Psoriatic--diagnostic imaging<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>Hand Joints--diagnostic imaging<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Radiography--methods<br/>Severity of Illness Index<br/>Treatment Outcome